Welcome to our dedicated page for Healthcare Svcs Group SEC filings (Ticker: HCSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Labor costs, contract renewals, Medicare exposure鈥擧ealthcare Services Group鈥檚 filings hide the numbers that decide its razor-thin margins. Finding whether a large nursing-home client quietly exited or how wage inflation squeezes quarterly earnings can take hours.
Stock Titan solves that. Our AI reads every Healthcare Services Group quarterly earnings report 10-Q filing and annual report 10-K simplified in seconds, surfacing segment revenue shifts, cafeteria cost trends, and union wage provisions. Need real-time Healthcare Services Group Form 4 insider transactions? You鈥檒l see alerts the moment executives trade.
Here鈥檚 how investors use the page:
- Track Healthcare Services Group insider trading Form 4 transactions to spot buybacks by directors before reimbursement updates.
- Compare facility-level margin data across periods with our Healthcare Services Group earnings report filing analysis.
- Open any 8-K material events explained to understand new or lost service contracts without parsing legalese.
Every document鈥攑roxy statement executive compensation, Healthcare Services Group 8-K material events explained, or Healthcare Services Group quarterly earnings report 10-Q filing鈥攃omes with AI-powered summaries that translate accounting jargon into plain English. AG真人官方-time feeds pull filings from EDGAR the instant they post, and key tables are tagged so you can export wage expense trends straight to Excel.
Stop scrolling through PDFs. Use Stock Titan for understanding Healthcare Services Group SEC documents with AI, from Healthcare Services Group insider trading Form 4 transactions real-time to the Healthcare Services Group annual report 10-K simplified. The insights you need are already highlighted.
Expro Group Holdings N.V. (XPRO) filed a Form 4 disclosing equity grants to its newly reported Chief Financial Officer, Sergio L. Maiworm Jr. On 30 June 2025, the executive received two separate awards of restricted stock units (RSUs):
- 286,041 RSUs that cliff-vest on 30 June 2028.
- 42,792 RSUs that vest one-third each on 30 June 2026, 2027 and 2028.
The combined 328,833 RSUs represent the CFO鈥檚 entire reported beneficial ownership following the transactions. Both awards were granted as inducement awards under NYSE Rule 303A.08 and were acquired at $0 cost, implying no open-market purchase or sale of common stock. No derivative securities were involved, and no dispositions were reported.
The multi-year vesting schedules aim to encourage long-term value creation, while the issuance of new shares introduces a modest dilutive element. No other financial metrics, sales, or option exercises were disclosed in the filing.
Leidos Holdings, Inc. (LDOS) 鈥� Form 4 insider transaction
Chief Financial Officer Christopher R. Cage reported one transaction dated 06/30/2025.
- Acquisition: 64.1944 shares of common stock credited at $0.00 per share. The shares represent dividend-equivalent rights that were automatically reinvested in the company鈥檚 Key Executive Stock Deferral Plan.
- Post-transaction ownership: 29,288.682 indirect shares held via the deferral plan and 46,953 direct shares.
No derivative securities were involved and no sales were disclosed. The filing does not indicate any open-market purchases or dispositions; the recorded activity is routine and non-cash. Given the immaterial share amount relative to the executive鈥檚 existing holdings, the filing is unlikely to have a meaningful impact on LDOS鈥檚 share count or market perception.